Who’s Going to Meeting on the Mesa 2026

What conference is this?

The Cell & Gene Meeting on the Mesa is the Alliance for Regenerative Medicine’s annual partnering meeting for the cell, gene and regenerative medicine industry, held October 5–7, 2026 at the Arizona Biltmore in Phoenix. It is a dealmaking meeting rather than a scientific congress: company presentations, one-to-one partnering and a program on manufacturing, financing, regulation and reimbursement.

What is in this guide?

Every organization we can place at Meeting on the Mesa 2026: all 583 of them, from the meeting’s own published attendee list, its 139 sponsors, and the 48 Innovation Spotlight presentations and program sessions — each with a short description of what the organization does. Speakers appear as job titles, never by name.

How are organizations typed?

By what they bring to a partnering meeting: therapy developers (cell and gene therapy companies, pharma and large biotech), the capital chasing them (venture, private equity and banks), the suppliers and services around them (CDMOs and CROs, tools and equipment, regulatory, logistics and consulting), and academic, hospital, nonprofit, government and media organizations. Focus areas come from the organization’s own profile where it publishes one, or from public sources otherwise.

Is the attendee list official?

Yes — the meeting publishes it. 330 of the organizations here appear on that list without also sponsoring or presenting, and their rows say so. The list names organizations only, never individual attendees.

How current is it?

Pulled from the public attendee list, sponsor directory, Innovation Spotlight listings and agenda on Sep 20 2026.